Could a simple timing change save thousands from cancer?
NCT ID NCT04722822
Summary
This study is testing if starting the HPV vaccine at age 9-10, instead of the recommended 11-12, leads more parents to get their children fully vaccinated. Researchers believe earlier timing might reduce parental hesitation and ensure protection before potential exposure to the virus. The goal is to find the best strategy to prevent HPV-related cancers by increasing vaccination rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California at Los Angeles
RECRUITINGLos Angeles, California, 90095, United States
Contact Email: •••••@•••••
Contact
-
University of Colorado
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.